1.
HIV-1 group P infection: towards a dead-end infection?
by Alessandri-Gradt, Elodie
AIDS (London), 2018-06-19, Vol.32 (10), p.1317-1322
2.
First evidence of transmission of an HIV-1 M/O intergroup recombinant virus
by Ngoupo, Paul Alain
AIDS (London), 2016-01-02, Vol.30 (1), p.1-8
3.
HIV-1 Genetic Diversity and Drug Resistance Mutations Among Treatment-Naive Adult Patients in Suriname
by Abdoel Wahid, Firoz
AIDS research and human retroviruses, 2016-12, Vol.32 (12), p.1223-1228
4.
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
by Hemelaar, Joris
The Lancet infectious diseases, 2018-11
5.
Defining HIV-1 transmission clusters based on sequence data
by Hassan, Amin S
AIDS (London), 2017-06-01, Vol.31 (9), p.1211-1222
6.
The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s
by Feng, Yi
AIDS (London), 2013-07-17, Vol.27 (11), p.1793-1802
7.
Global trends in molecular epidemiology of HIV-1 during 2000-2007
by HEMELAAR, Joris
AIDS (London), 2011, Vol.25 (5), p.679-689
8.
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus
by Thompson, Melanie
AIDS (London), 2016-03-27, Vol.30 (6), p.869-878
9.
Challenges in the development of an HIV-1 vaccine
by Barouch, Dan H
Nature, 2008-10-02, Vol.455 (7213), p.613-619
10.
Nationwide Trends in Molecular Epidemiology of HIV-1 in China
by Li, Xiaoshan
AIDS research and human retroviruses, 2016-09, Vol.32 (9), p.851-859
11.
Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease
by Tebit, Denis M, PhD
The Lancet infectious diseases, 2011, Vol.11 (1), p.45-56
12.
Large cluster outbreaks sustain the HIV epidemic among MSM in Quebec
by Brenner, Bluma G
AIDS (London), 2017-03-13, Vol.31 (5), p.707-717
13.
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
by Mullins, James I
Nature medicine, 2011-03, Vol.17 (3), p.366-371
14.
Recombination Analysis of Near Full-Length HIV-1 Sequences and the Identification of a Potential New Circulating Recombinant Form from Rakai, Uganda
by Capoferri, Adam A
AIDS research and human retroviruses, 2020-06, Vol.36 (6), p.467-474
15.
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960
by Kabongo, Jean-Marie M
Nature, 2008-10-02, Vol.455 (7213), p.661-664
16.
Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana
by Seatla, Kaelo K
AIDS (London), 2018-08-24, Vol.32 (13), p.1899-1902
17.
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
by HEMELAAR, Joris
AIDS (London), 2006, Vol.20 (16), p.W13-W23
18.
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes
by Neogi, Ujjwal
AIDS (London), 2018-02-20, Vol.32 (4), p.469-476
19.
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
by Girard, Marc P
Vaccine, 2011, Vol.29 (37), p.6191-6218
20.
CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission
by Li, Yijia
AIDS (London), 2014-02-20, Vol.28 (4), p.521-530
